222 related articles for article (PubMed ID: 31457089)
1. Cell cycle progression in confining microenvironments is regulated by a growth-responsive TRPV4-PI3K/Akt-p27
Nam S; Gupta VK; Lee HP; Lee JY; Wisdom KM; Varma S; Flaum EM; Davis C; West RB; Chaudhuri O
Sci Adv; 2019 Aug; 5(8):eaaw6171. PubMed ID: 31457089
[TBL] [Abstract][Full Text] [Related]
2. The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.
Li A; Wang J; Wu M; Zhang X; Zhang H
Eur J Pharmacol; 2015 Jan; 747():71-87. PubMed ID: 25498792
[TBL] [Abstract][Full Text] [Related]
3. BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway.
Gesbert F; Sellers WR; Signoretti S; Loda M; Griffin JD
J Biol Chem; 2000 Dec; 275(50):39223-30. PubMed ID: 11010972
[TBL] [Abstract][Full Text] [Related]
4. PI3K/AKT pathway-mediated regulation of p27(Kip1) is associated with cell cycle arrest and apoptosis in cervical cancer.
Prasad SB; Yadav SS; Das M; Modi A; Kumari S; Pandey LK; Singh S; Pradhan S; Narayan G
Cell Oncol (Dordr); 2015 Jun; 38(3):215-25. PubMed ID: 25821107
[TBL] [Abstract][Full Text] [Related]
5. Upregulated hsa_circRNA_100269 inhibits the growth and metastasis of gastric cancer through inactivating PI3K/Akt axis.
Wang Z; Liu C
PLoS One; 2021; 16(4):e0250603. PubMed ID: 33901239
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3K/Akt pathway.
Li GQ; Xie J; Lei XY; Zhang L
World J Gastroenterol; 2009 Nov; 15(44):5541-8. PubMed ID: 19938192
[TBL] [Abstract][Full Text] [Related]
7. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression.
Cappellini A; Tabellini G; Zweyer M; Bortul R; Tazzari PL; Billi AM; Falà F; Cocco L; Martelli AM
Leukemia; 2003 Nov; 17(11):2157-67. PubMed ID: 12931221
[TBL] [Abstract][Full Text] [Related]
8. PI3K/Akt/FOXO3a pathway contributes to thrombopoietin-induced proliferation of primary megakaryocytes in vitro and in vivo via modulation of p27(Kip1).
Nakao T; Geddis AE; Fox NE; Kaushansky K
Cell Cycle; 2008 Jan; 7(2):257-66. PubMed ID: 18256550
[TBL] [Abstract][Full Text] [Related]
9. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-1 promotes G(1)/S cell cycle progression through bidirectional regulation of cyclins and cyclin-dependent kinase inhibitors via the phosphatidylinositol 3-kinase/Akt pathway in developing rat cerebral cortex.
Mairet-Coello G; Tury A; DiCicco-Bloom E
J Neurosci; 2009 Jan; 29(3):775-88. PubMed ID: 19158303
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-200a Affects the Proliferation of Airway Smooth Muscle Cells and Airway Remodeling by Targeting FOXC1 via the PI3K/AKT Signaling Pathway in Ovalbumin-Induced Asthmatic Mice.
Liu Y; Miao Y; Gao X; Wang YY; Wang H; Zheng YW; Zhao ZY
Cell Physiol Biochem; 2018; 50(6):2365-2389. PubMed ID: 30423573
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation of the mixed lineage leukemia-p27Kip1 pathway by a somatostatin analogue.
Horiguchi K; Yamada M; Satoh T; Hashimoto K; Hirato J; Tosaka M; Yamada S; Mori M
Clin Cancer Res; 2009 Apr; 15(8):2620-9. PubMed ID: 19318494
[TBL] [Abstract][Full Text] [Related]
13. Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization.
Motti ML; Califano D; Troncone G; De Marco C; Migliaccio I; Palmieri E; Pezzullo L; Palombini L; Fusco A; Viglietto G
Am J Pathol; 2005 Mar; 166(3):737-49. PubMed ID: 15743786
[TBL] [Abstract][Full Text] [Related]
14. The death domain-containing kinase RIP1 regulates p27(Kip1) levels through the PI3K-Akt-forkhead pathway.
Park S; Ramnarain DB; Hatanpaa KJ; Mickey BE; Saha D; Paulmurugan R; Madden CJ; Wright PS; Bhai S; Ali MA; Puttaparthi K; Hu W; Elliott JL; Stuve O; Habib AA
EMBO Rep; 2008 Aug; 9(8):766-73. PubMed ID: 18566599
[TBL] [Abstract][Full Text] [Related]
15. PI3K/Akt signaling regulates p27(kip1) expression via Skp2 in PC3 and DU145 prostate cancer cells, but is not a major factor in p27(kip1) regulation in LNCaP and PC346 cells.
van Duijn PW; Trapman J
Prostate; 2006 May; 66(7):749-60. PubMed ID: 16425184
[TBL] [Abstract][Full Text] [Related]
16. Photobiomodulation with 630-nm LED radiation inhibits the proliferation of human synoviocyte MH7A cells possibly via TRPV4/PI3K/AKT/mTOR signaling pathway.
Meng C; Xia Q; Wu H; Huang H; Liu H; Li Y; Zhang F; Song W
Lasers Med Sci; 2020 Dec; 35(9):1927-1936. PubMed ID: 32162133
[TBL] [Abstract][Full Text] [Related]
17. PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25A.
Patsoukis N; Sari D; Boussiotis VA
Cell Cycle; 2012 Dec; 11(23):4305-9. PubMed ID: 23032366
[TBL] [Abstract][Full Text] [Related]
18. [Rosiglitazone inhibits human HepG2 cell proliferation via PI3K/PTEN/Akt signaling pathway].
Zhang M; Peng L; Qiao Z; He H; Zhou Y; Xu Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Feb; 30(2):147-50. PubMed ID: 24491054
[TBL] [Abstract][Full Text] [Related]
19. The TRPV4-AKT axis promotes oral squamous cell carcinoma cell proliferation via CaMKII activation.
Fujii S; Tajiri Y; Hasegawa K; Matsumoto S; Yoshimoto RU; Wada H; Kishida S; Kido MA; Yoshikawa H; Ozeki S; Kiyoshima T
Lab Invest; 2020 Feb; 100(2):311-323. PubMed ID: 31857698
[TBL] [Abstract][Full Text] [Related]
20. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
